CapsoVision (CV) Gross Margin (2024 - 2025)
CapsoVision recorded quarterly Gross Margin of 49.87% in Q4 2025, down 7.81% quarter-over-quarter from 54.1% in Q3 2025, and down 36.0% year-over-year from 77.93% in Q4 2024.
CapsoVision's Gross Margin history runs 2 years deep, the most recent figure standing at 49.87% for Q4 2025.
- In Q4 2025, Gross Margin fell 36.0% year-over-year to 49.87%; the TTM figure through Dec 2025 stood at 52.12% (changed N/A YoY), while the FY2025 annual figure was 52.92%, down 132.0% from the prior year.
- Gross Margin came in at 49.87% for Q4 2025 at CapsoVision, down from 54.1% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 56.0% in Q2 2024 to a low of 49.87% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | CapsoVision | 167.59 Mn | 157.48 Mn | 1.95 Mn | 49.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.87% |
| Sep 30, 2025 | 54.10% |
| Jun 30, 2025 | 54.63% |
| Dec 31, 2024 | 50.23% |
| Sep 30, 2024 | 55.87% |
| Jun 30, 2024 | 56.00% |